A Single Center, Randomized, Double-blind, Double-dummy, Placebo- and Active-controlled, Six-way Crossover Single-dose Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Central Nervous System (CNS) Depressant Drug Users
Latest Information Update: 23 Feb 2016
Price :
$35 *
At a glance
- Drugs Almorexant (Primary) ; Zolpidem
- Indications Insomnia; Obesity
- Focus Therapeutic Use
- Sponsors Actelion Pharmaceuticals; Midnight Pharma
- 25 Nov 2013 New trial record